Fosmetpantotenate
Product Specifications
UNSPSC Description
Fosmetpantotenate is a phosphopantothenic acid (PPA) precursor designed to release PPA intracellularly, leading to restoration of CoA levels. Fosmetpantotenate is used to research pantothenate kinase-associated neurodegeneration.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fosmetpantotenate.html
Solubility
10 mM in DMSO
Smiles
COC(CCNC([C@H](O)C(C)(C)COP(OC1=CC=CC=C1)(N[C@@H](C)C(OC)=O)=O)=O)=O
Molecular Weight
474.44
References & Citations
[1]Elbaum D, Beconi MG, Monteagudo E, et al. Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models. PLoS One. 2018;13(3):e0192028. Published 2018 Mar 9. |[2]Klopstock T, et al. The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration. Clin Trials. 2019;16(4):410-418.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-109033/Fosmetpantotenate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-109033/
Clinical Information
Phase 3
CAS Number
1858268-66-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items